Growth & Prosperity Blog

Building Momentum, Building Reputation: August 15, 2018 Portfolio Update

OIF Portfolio Companies Move Forward with Expansions, Funding & More

From longtime members to relative newcomers, the Ohio Innovation Fund’s portfolio companies are implementing plans to increase their visibility in their markets and grow their businesses. Read on to learn about some of the big plans being put into motion by OIF portfolio companies.

 

RXQ Compounding is the Newest Addition to OIF’s Portfolio Companies

When sterile and non-sterile medication manufacturer RXQ Compounding LLC announced its $7 million in Series A funding in late July, at the top of the list of investors was the Ohio Innovation Fund. The Athens-based pharmaceutical company, which has been in business four years, plans to use the funding to open a state-of-the-art outsourcing facility for pharmacy compounding, adding as many as 100 jobs.

“This investment will help RXQ open a new world-class compounding facility, boosting our ability to further serve our customers and expand our line of products. We’re excited to be supported by OIF, which has a proven track record in the region, including multiple IPOs and major acquisitions in both the technology and medical technology industries.” –RXQ Compounding CEO Ed Zatta

 Read more about RXQ’s plans here.

 

Cool Office! Stirling Ultracold Adds Design & Marketing to Columbus Space

Athens-based Global Cooling, maker of the Stirling Ultracold ultra-low temperature freezer, opened a new sales office in Columbus earlier this summer, giving a big boost to its growth potential. A recent Columbus Business First story recaps the process of opening the office in the Smith Brothers Hardware building, just north of downtown Columbus, and its evolution to also house the company’s marketing and design arms.

Read the whole article here.

 

Enable Injections Spotlights enFuze in Look at Pharmaceutical Adherence

Wearable drug delivery company Enable Injections recently had the opportunity to explain its enFuse™ large-volume device for a feature on medical adherence solutions in pharmaceutical marketing publication PM360. In the article, the Cincinnati developer and manufacturer explains the wearable’s convenience, ability to reduce injection anxiety and quick warming for refrigerated medications as a few of its key features.

Read the feature in its entirety here.

OIF portfolio company Wiretap was recently recognized as well, being named one of The Tech Tribune’s top 10 Columbus tech startups looking forward to 2019.

 

Interested in more news from each of our portfolio companies on a daily basis? Follow Ohio Innovation Fund on Twitter & Facebook!

Building Momentum, Building Reputation: August 15, 2018 Portfolio Update